KAZIA THERAPEUTICS-SPON ADR
KZIANASDAQ🏆 #3373 by market capEarnings Sep 4US Equity
$13.88▼ $0.07 (−0.50%)
🌅 Pre-market$13.86▼ 0.14%Regular close · extended-hours price shown1h—
24h▼ 0.5%
7d▲ 16.2%
14d▲ 14.6%
30d▲ 2.0%
1y▲ 70.7%
🏦Market Cap
$74.48B
Mid Cap
📈Revenue Growth (YoY)
-89.5%
Declining
📊Gross Margin
77.7%
High
💵FCF Margin
—
⚖️P/S Ratio
911.7x
Expensive
Otter Score
50
Weak
Earnings
Q1 · 2026Reported 2026-03-16Earnings Per Share
Actual
-0.58
Expected
-0.01
miss
−8205.20%
Revenue
Actual
$216.90K
Expected
—
—
—
Consensus estimates
Recent quarters
Q1 2026
-0.58
miss
Q4 2025
-0.43
miss
Q2 2025
-7.61
beat
Q4 2024
-20.81
miss